Pre-eclampsia
B Sibai, G Dekker, M Kupferminc - The Lancet, 2005 - thelancet.com
Pre-eclampsia is a major cause of maternal mortality (15–20% in developed countries) and
morbidities (acute and long-term), perinatal deaths, preterm birth, and intrauterine growth …
morbidities (acute and long-term), perinatal deaths, preterm birth, and intrauterine growth …
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis
Background Preeclampsia and fetal growth restriction are major causes of perinatal death
and handicap in survivors. Randomized clinical trials have reported that the risk of …
and handicap in survivors. Randomized clinical trials have reported that the risk of …
Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force
Importance Preeclampsia is a hypertensive disorder of pregnancy that poses serious
maternal and infant health risks. Previous systematic reviews have established benefits of …
maternal and infant health risks. Previous systematic reviews have established benefits of …
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis
Objective Data Metaanalyses of randomized controlled trials have reported contradictory
results about the effect of aspirin in the prevention of preeclampsia, both in terms of the …
results about the effect of aspirin in the prevention of preeclampsia, both in terms of the …
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis
OBJECTIVE: To estimate the effect of low-dose aspirin started in early pregnancy on the
incidence of preeclampsia and intrauterine growth restriction (IUGR). DATA SOURCES: A …
incidence of preeclampsia and intrauterine growth restriction (IUGR). DATA SOURCES: A …
Antiplatelet agents for preventing pre‐eclampsia and its complications
L Duley, S Meher, KE Hunter… - … of systematic reviews, 2019 - cochranelibrary.com
Background Pre‐eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
LM Askie, L Duley, DJ Henderson-Smart, LA Stewart - The Lancet, 2007 - thelancet.com
Background Pre-eclampsia is a major cause of mortality and morbidity during pregnancy
and childbirth. Antiplatelet agents, especially low-dose aspirin, might prevent or delay pre …
and childbirth. Antiplatelet agents, especially low-dose aspirin, might prevent or delay pre …
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force
Background: Preeclampsia is a leading cause of maternal and perinatal morbidity and
mortality. Purpose: To systematically review benefits and harms of low-dose aspirin for …
mortality. Purpose: To systematically review benefits and harms of low-dose aspirin for …
Preeclampsia
The authors review hypertensive disease during pregnancy with an academic and practical
view, and using the best evidence available. This disease, which is the most important …
view, and using the best evidence available. This disease, which is the most important …
Prevention of perinatal death and adverse perinatal outcome using low‐dose aspirin: a meta‐analysis
Objective To compare early vs late administration of low‐dose aspirin on the risk of perinatal
death and adverse perinatal outcome. Methods Databases were searched for keywords …
death and adverse perinatal outcome. Methods Databases were searched for keywords …